Back to Journals » OncoTargets and Therapy » Volume 13

IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma

Total article views   HTML views PDF downloads Totals
8,760 Dovepress* 6,720+ 1,308 8,028
PubMed Central* 2,040 522 2,562
Totals 8,760 1,830 10,590
*Since 5 February 2020

View citations on PubMed Central and Google Scholar